Streamline Health Solutions Gross Profit

The latest gross profit for STRM is $8.9B as of April 2025. That compares with $11M in the prior-year period — up 79065.1% year over year. That is below the Technology sector average of $260B. Investors often review this figure alongside Streamline Health Solutions's historical trend and sector peers before judging valuation or financial health.

Over the past year, STRM's gross profit moved from $11M to $8.9B — a 79065.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Streamline Health Solutions's operating scale or balance-sheet position.

Against Technology companies, STRM currently prints $8.9B for gross profit, while the sector average sits near $260B. That is roughly 96.6% below the sector mean. Large gaps often invite a closer look at Streamline Health Solutions's growth, margins, and balance sheet.

A gross profit figure of $8.9B for STRM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $260B. Explore the charts below for those layers of context.

After noting STRM's gross profit ($8.9B), review year-over-year change from $11M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.